================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________
SCHEDULE 13D
Under the Securities Exchange Act of 1934
_______________________
WORLD WRESTLING FEDERATION ENTERTAINMENT, INC.
(Name of Issuer)
CLASS A COMMON STOCK, PAR VALUE $0.01 PER SHARE
(Title of Class of Securities)
98156Q108
(CUSIP Number)
MS. SUZANNE M. PRESENT
INVEMED CATALYST FUND, L.P.
375 PARK AVENUE
SUITE 2205
NEW YORK, NY 10152
TEL. NO.: (212) 843-0542
(Name, Address and Telephone Number of
Person Authorized to Receive Notices
and Communications)
_______________________
AUGUST 30, 2001
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(e), 1(f) or 1(g), check the following
box [_].
Note: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule 13d-1(a) for
other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
================================================================================
------------------------ -------------------------
98156Q108 PAGE 2 OF 12 PAGES
------------------------ -------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Invemed Catalyst Fund, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
2,582,773 shares of Class A Common
Stock, par value $0.01
NUMBER OF SHARES ------------------------------------------------
BENEFICIALLY OWNED 8 SHARED VOTING POWER
BY EACH REPORTING
PERSON None
WITH ------------------------------------------------
9 SOLE DISPOSITIVE POWER
2,582,773 shares of Class A Common
Stock, par value $0.01
------------------------------------------------
10 SHARED DISPOSITIVE POWER
None
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,582,773 shares of Class A Common Stock, par value $0.01
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[_]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.23%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
PN
--------------------------------------------------------------------------------
------------------------ -------------------------
98156Q108 PAGE 3 OF 12 PAGES
------------------------ -------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Invemed Catalyst GenPar, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
2,582,773 shares of Class A Common
Stock, par value $0.01
NUMBER OF SHARES ------------------------------------------------
BENEFICIALLY OWNED 8 SHARED VOTING POWER
BY EACH REPORTING
PERSON None
WITH ------------------------------------------------
9 SOLE DISPOSITIVE POWER
2,582,773 shares of Class A Common
Stock, par value $0.01
------------------------------------------------
10 SHARED DISPOSITIVE POWER
None
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,582,773 shares of Class A Common Stock, par value $0.01
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[_]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.23%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
OO
--------------------------------------------------------------------------------
------------------------ -------------------------
98156Q108 PAGE 4 OF 12 PAGES
------------------------ -------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Gladwyne Catalyst GenPar, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
NUMBER OF SHARES ------------------------------------------------
BENEFICIALLY OWNED 8 SHARED VOTING POWER
BY EACH REPORTING
PERSON 2,582,773 shares of Class A Common
WITH Stock, par value $0.01
------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
------------------------------------------------
10 SHARED DISPOSITIVE POWER
2,582,773 shares of Class A Common
Stock, par value $0.01
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,582,773 shares of Class A Common Stock, par value $0.01
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[_]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.23%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
OO
--------------------------------------------------------------------------------
------------------------ -------------------------
98156Q108 PAGE 5 OF 12 PAGES
------------------------ -------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Invemed Securities, Inc.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
NUMBER OF SHARES ------------------------------------------------
BENEFICIALLY OWNED 8 SHARED VOTING POWER
BY EACH REPORTING
PERSON 2,582,773 shares of Class A Common
WITH Stock, par value $0.01
------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
------------------------------------------------
10 SHARED DISPOSITIVE POWER
2,582,773 shares of Class A Common
Stock, par value $0.01
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,582,773 shares of Class A Common Stock, par value $0.01
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[_]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.23%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
--------------------------------------------------------------------------------
------------------------ -------------------------
98156Q108 PAGE 6 OF 12 PAGES
------------------------ -------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Kenneth G. Langone
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [_]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
NUMBER OF SHARES ------------------------------------------------
BENEFICIALLY OWNED 8 SHARED VOTING POWER
BY EACH REPORTING
PERSON 2,582,773 shares of Class A Common
WITH Stock, par value $0.01
------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
------------------------------------------------
10 SHARED DISPOSITIVE POWER
2,582,773 shares of Class A Common
Stock, par value $0.01
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,582,773 shares of Class A Common Stock, par value $0.01
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[_]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.23%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
------------------------ -------------------------
98156Q108 PAGE 7 OF 12 PAGES
------------------------ -------------------------
ITEM 1. SECURITY AND ISSUER.
This Statement on Schedule 13D (this "Statement") relates to the Class
A Common Stock, par value $.01 per share (the "Common Stock"), of World
Wrestling Federation Entertainment, Inc., a Delaware corporation (the "Issuer").
The principal executive offices of the Issuer are located at 1241 East Main
Street, Stamford, CT 06902.
ITEM 2. IDENTITY AND BACKGROUND.
(a) Invemed Catalyst Fund, L.P., a Delaware limited partnership (the
"Fund"), Invemed Catalyst GenPar, LLC, a Delaware limited liability company
("Catalyst GenPar"), Gladwyne Catalyst GenPar, LLC, a Delaware limited liability
company ("Gladwyne GenPar"), Invemed Securities, Inc. ("Invemed"), a New York
corporation, and Kenneth G. Langone ("Langone") are sometimes hereinafter
collectively referred to as the "Reporting Persons."
The Reporting Persons are making this joint filing because they may be
deemed to constitute a "group" within the meaning of Section 13(d)(3) of the
Securities Exchange Act of 1934, although neither the fact of this filing nor
anything contained herein shall be deemed to be an admission by the Reporting
Persons that a group exists.
(b)-(c)(i) The principal business of the Fund is investing in
securities. The business address of the Fund is 375 Park Avenue, Suite 2205, New
York, New York 10152. The general partner of the Fund is Catalyst GenPar. The
principal business of Catalyst GenPar is being the general partner of the Fund.
(ii) The business address of Catalyst GenPar is 375 Park
Avenue, Suite 2205, New York, NY 10152. The managing members of Catalyst GenPar
are Gladwyne GenPar and Invemed.
(iii) The principal business of Gladwyne GenPar is being a
managing member of Catalyst GenPar. The business address of Gladwyne GenPar is
600 The Times Building, Ardmore, PA 19003.
The name, residence or business address, present principal occupation
and citizenship of each member of Gladwyne GenPar are as follows:
---------------------------- ------------------------------ --------------------------- ---------------------
NAME RESIDENCE OR PRINCIPAL CITIZENSHIP
BUSINESS ADDRESS OCCUPATION
---------------------------- ------------------------------ --------------------------- ---------------------
Michael B. Solomon 600 The Times Building Member of Gladwyne GenPar United States
Ardmore, PA 19003
---------------------------- ------------------------------ --------------------------- ---------------------
Suzanne M. Present 600 The Times Building Member of Gladwyne GenPar Australia
Ardmore, PA 19003
---------------------------- ------------------------------ --------------------------- ---------------------
------------------------ -------------------------
98156Q108 PAGE 8 OF 12 PAGES
------------------------ -------------------------
---------------------------- ------------------------------ --------------------------- ---------------------
NAME RESIDENCE OR PRINCIPAL CITIZENSHIP
BUSINESS ADDRESS OCCUPATION
---------------------------- ------------------------------ --------------------------- ---------------------
Kathryn Casoria 600 The Times Building Member of Gladwyne GenPar United States
Ardmore, PA 19003
---------------------------- ------------------------------ --------------------------- ---------------------
Robert B. Friedman 600 The Times Building Member of Gladwyne GenPar United States
Ardmore, PA 19003
---------------------------- ------------------------------ --------------------------- ---------------------
Philip P. Young 600 The Times Building Member of Gladwyne GenPar United States
Ardmore, PA 19003
---------------------------- ------------------------------ --------------------------- ---------------------
William M. Sams 600 The Times Building Member of Gladwyne GenPar United States
Ardmore, PA 19003
---------------------------- ------------------------------ --------------------------- ---------------------
(iv) Invemed's principal business is that of a holding
company. The business address of Invemed is 375 Park Avenue, Suite 2205, New
York, NY 10152. Invemed is ultimately controlled by Kenneth G. Langone.
The name, current business address, present principal occupation or
employment and citizenship of each director and executive officer of Invemed
Securities, Inc. are as follows:
---------------------------- ------------------------------ --------------------------- ---------------------
NAME RESIDENCE OR PRINCIPAL CITIZENSHIP
BUSINESS ADDRESS OCCUPATION
---------------------------- ------------------------------ --------------------------- ---------------------
Kenneth G. Langone 375 Park Avennue Chief Executive Officer, United States
Suite 2205 Invemed Securities, Inc.
New York, NY 10152
---------------------------- ------------------------------ --------------------------- ---------------------
Thomas Teague Salem NationalLease President, Salem United States
Corporation NationalLease
P.O. Box 24788 Corporation
Winston-Salem, NC
27114
---------------------------- ------------------------------ --------------------------- ---------------------
G. Allen Mebane 828 Woodward Road United States
Mocksville, NC 27028
---------------------------- ------------------------------ --------------------------- ---------------------
John Baran 375 Park Avennue Chief Executive Officer, United States
Suite 2205 Invemed Securities, Inc.
New York, NY 10152
---------------------------- ------------------------------ --------------------------- ---------------------
------------------------ -------------------------
98156Q108 PAGE 9 OF 12 PAGES
------------------------ -------------------------
(iv) Kenneth G. Langone's current principal occupation is
that of Chief Executive Officer of Invemed, and his business address is 375
Park Avenue, Suite 2205, New York, NY 10152.
(d)-(e) None of the Reporting Persons and none of the individuals
listed in this Item 2 has, during the last five years, been (i) convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors) or
(ii) a party to a civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was or is subject to a
judgment, decree or final order enjoining future violations of, or prohibited or
mandating activities subject to, federal or state securities laws or finding any
violation with respect to such laws.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
Pursuant to a Stock Purchase Agreement, dated as of August 23, 2001,
between the Fund and Vincent K. McMahon, in his capacity as trustee of The
Vincent K. McMahon Irrevocable Trust (the "Trust"), the Fund agreed to purchase
1,886,793 shares of Common Stock.
Prior to the purchase referred to in the preceding paragraph, the
Reporting Persons acquired 695,980 shares of Common Stock in open market
purchase using the Fund's capital.
The purchase was completed on August 30, 2001. The shares of Common
Stock referred to in the Stock Purchase Agreement were shares of class B common
stock, par value $0.01 per share (the "Class B Common Stock") of the Issuer,
that were converted into Common Stock immediately prior to the purchase referred
to herein. The $25,000,007.25 purchase price for the 1,886,793 shares of Common
Stock acquired by the Reporting Persons was derived from the Fund's capital.
ITEM 4. PURPOSE OF TRANSACTION.
The Reporting Persons acquired the shares of Common Stock for
investment purposes. The Reporting Persons may from time to time (i) acquire
additional securities of the Issuer (subject to availability at prices deemed
favorable) in the open market, in privately negotiated transactions or
otherwise, or (ii) dispose of the shares of Common Stock or any other securities
of the Issuer that the Reporting Persons may acquire, when prices are deemed
favorable in the open market, in privately negotiated transactions or otherwise.
(d) The members of the board of directors of the Issuer executed a
written consent, dated August 30, 2001, pursuant to which they increased the
size of the board of directors of the Issuer and elected Mr. Solomon as a
director to fill in the directorship position created thereby. Also, on August
30, 2001, the Fund, the Trust and Mr. McMahon executed a Stockholders Agreement
pursuant to which the Trust and Mr. McMahon agreed that they would vote their
shares of capital stock of the Issuer in favor of the election of Mr. Solomon or
a qualified successor as a director of the Issuer.
------------------------ -------------------------
98156Q108 PAGE 10 OF 12 PAGES
------------------------ -------------------------
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) As of the date of this Statement, the Fund beneficially owns
2,582,773 shares of Common Stock constituting 14.23% of the outstanding shares
of Common Stock (the percentage of shares owned being based upon 16,265,384
shares of Common Stock outstanding as of July 26, 2001, as disclosed in the
proxy statement on proxy statement on Schedule 14A filed by the Issuer on August
17, 2001). Each of the persons listed in Item 2 of this Statement may also be
deemed to beneficially own (as that term is defined in Rule 13d-3 under the
Securities Exchange Act of 1934) the 2,582,773 shares of Common Stock
constituting 14.23% of the outstanding shares of the Issuer. However, the
persons listed on Item 2 of this Statement (other than the Fund) disclaims
beneficial ownership of such shares of Common Stock.
(b) The Fund has sole power to vote and dispose the 2,582,773 shares
reported herein. Catalyst GenPar, as the general partner of the Fund, has the
sole power to vote and dispose of the 2,582,773 shares of Common Stock owned by
the Fund. Each of Gladwyne GenPar and Invemed, as managing members of Catalyst
GenPar, may be deemed to have shared voting and dispositive power over the
shares of Common Stock owned by the Fund. Kenneth G. Langone, as the principal
shareholder and Chief Executive Officer of Invemed, may be deemed to have shared
voting and dispositive power over the shares of Common Stock owned by the Fund.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIP WITH
RESPECT TO THE ISSUER.
The members of Gladwyne GenPar are authorized and empowered to vote and
dispose of the securities held by the Fund. Accordingly, Gladwyne GenPar and the
members of Gladwyne GenPar may, from time to time, consult among themselves and
coordinate the voting and disposition of the Issuer's shares of Common Stock as
well as such other action taken on behalf of the Reporting Persons with respect
to the Issuer's shares of Common Stock as they deem to be in the collective
interest of the Reporting Persons.
On August 30, 2001 and in connection with the consummation of the
transactions contemplated by the Stock Purchase Agreement, the Fund, the Trust
and Mr. McMahon entered into a Stockholders Agreement pursuant to which the
Trust and Mr. McMahon agreed to elect a representative of the Fund to the
Issuer's board of directors, as described therein.
On August 30, 2001 and in connection with the consummation of the
transactions contemplated by the Stock Purchase Agreement, the Issuer and the
Fund entered into the Registration Rights Agreement, dated as of August 30, 2001
(the "Registration Rights Agreement"). Pursuant to the Registration Rights
Agreement, the Fund has been granted certain shelf and incidental registration
rights with respect to its shares of Common Stock.
The foregoing summaries of the Stock Purchase Agreement, the
Registration Rights Agreement and the Stockholders Agreement are qualified in
their entirety by reference to Exhibits 2, 3 and 4 which are incorporated herein
by reference.
------------------------ -------------------------
98156Q108 PAGE 11 OF 12 PAGES
------------------------ -------------------------
ITEM 7. MATERIALS TO BE FILED AS EXHIBITS.
Exhibit 1: Agreement relating to the filing of joint acquisition
statements as required by Rule 13d-1(k)(1) under the
Securities Exchange Act of 1934, as amended.
Exhibit 2: Stock Purchase Agreement, dated as of August 23, 2001,
between Vincent K. McMahon, in his capacity as trustee on
behalf of the Trust and the Fund.
Exhibit 3: Stockholders Agreement, dated as of August 30, 2001, between the
Trust, Vincent K. McMahon and the Fund.
Exhibit 4: Registration Rights Agreement, dated as of August 30,
2001, between the Issuer and the Fund.
------------------------ -------------------------
98156Q108 PAGE 12 OF 12 PAGES
------------------------ -------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated as of August 30, 2001.
INVEMED CATALYST FUND, L.P.
By: INVEMED CATALYST GENPAR, LLC,
General Partner
By: GLADWYNE CATALYST GENPAR, LLC,
Managing Member
By: /s/ Suzanne Present
-----------------------
Name: Suzanne Present
Title: Member
INVEMED CATALYST GENPAR, LLC
By: GLADWYNE CATALYST GENPAR, LLC,
Managing Member
By: /s/ Suzanne Present
----------------------------
Name: Suzanne Present
Title: Member
GLADWYNE CATALYST GENPAR, LLC
By: /s/ Suzanne Present
-----------------------------------
Name: Suzanne Present
Title: Member
INVEMED SECURITIES, INC.
By: /s/ Kenneth G. Langone
-----------------------------------
Name: Kenneth G. Langone
Title: Chief Executive Officer
/s/ Kenneth G. Langone
----------------------------------------
Kenneth G. Langone